
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.940 | 13.600 | 12.660 |
Shares | 99.060 | 99.060 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 29.230 | 32.145 |
Price to Book | - | 4.504 |
Price to Sales | 3.841 | 5.117 |
Price to Cash Flow | 18.783 | 22.245 |
Dividend Yield | 0.435 | 0.713 |
5 Years Earnings Growth | 16.918 | 15.669 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 79.580 | 96.105 |
Energy | 8.080 | 8.080 |
Consumer Defensive | 6.710 | 6.710 |
Technology | 5.620 | 5.620 |
Number of long holdings: 19
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Divi's Labs | INE361B01024 | 9.59 | 6,483.00 | -0.84% | |
Aster DM Healthcare | INE914M01019 | 8.99 | 553.80 | -2.81% | |
RPG Life Sciences Limited | INE105J01010 | 7.95 | 2,188.80 | +0.76% | |
Torrent Pharma | INE685A01028 | 7.03 | 3,174.70 | -1.16% | |
Reliance Industries | INE002A01018 | 6.89 | 1,426.80 | +1.23% | |
Alivus Life Sciences | INE03Q201024 | 6.87 | 1,117.00 | +1.21% | |
Aurobindo Pharma | INE406A01037 | 6.74 | 1,197.10 | +0.75% | |
Future on Lupin Ltd | - | 6.46 | - | - | |
Zydus Wellness | INE768C01010 | 5.72 | 1,952.90 | -0.58% | |
Pfizer Ltd | INE182A01018 | 5.23 | 5,147.80 | +0.16% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
INF966L01689 | 262.22B | -8.61 | 22.55 | 19.69 | ||
INF966L01051 | 262.22B | -8.89 | 21.16 | 18.82 | ||
Quant Mid Cap Fund Growth | 87.76B | -4.45 | 18.59 | 16.49 | ||
INF966L01887 | 87.76B | -4.09 | 20.41 | 17.74 | ||
Quant Consumption Fund Growth | 70.16B | -1.61 | 17.63 | 18.72 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review